“Repeated-dose toxicology studies of adequate duration and at MTDs were performed in rats and dogs.”
✓ VerifiedFDA pharmacology/toxicology review, p. 132Source ↗
Why that species
Both major human metabolites (1-PP, 3'-OH-gepirone) are present at substantial levels in rat and dog plasma
“In humans, 2 major metabolites of gepirone have been identified: 1-PP (which is also a metabolite of buspirone, currently approved and marketed as an anxiolytic) and 3’-OH-gepirone. Both of these metabolites have been identified and found to be present in substantial amounts (many times the levels of gepirone) in plasma of the 2 major species used in the preclinical studies, namely rats and dogs, following gepirone administration.”
✓ VerifiedFDA pharmacology/toxicology review, p. 132Source ↗
Surrogate molecule
No surrogate; the clinical compound was tested
“In the 1-year study in dogs (4, 8, and 16 mg/kg/day orally, in a capsule), decreases in body weights (and food consumption at the HD) limited doses.”
✓ VerifiedFDA pharmacology/toxicology review, p. 132Source ↗
Species: general tox
Rat and dog
“Repeated-dose toxicology studies of adequate duration and at MTDs were performed in rats and dogs.”
✓ VerifiedFDA pharmacology/toxicology review, p. 132Source ↗
Species: DART
Rat (EFD, pre/postnatal) and rabbit (EFD)
“traditional Segment II studies, in rats and rabbits, with oral gavage dosing of pregnant females during the period of organogenesis; and 3) a traditional Segment III study in rats, with oral gavage dosing of pregnant females from late pregnancy through lactation”
✓ VerifiedFDA pharmacology/toxicology review, p. 133Source ↗
Species: carcinogenicity
Rat and mouse (2-year bioassays)
“More importantly, there was no evidence of carcinogenic potential in the completed two-year mouse and rat bioassays.”
✓ VerifiedFDA pharmacology/toxicology review, p. 22Source ↗
Surrogate used in
No surrogate used; rat and dog form the major human metabolites
“Both of these metabolites have been identified and found to be present in substantial amounts (many times the levels of gepirone) in plasma of the 2 major species used in the preclinical studies, namely rats and dogs, following gepirone administration.”
✓ VerifiedFDA pharmacology/toxicology review, p. 132Source ↗